Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial
প্রধান লেখক: | Vora, A, Goulden, N, Wade, R, Mitchell, C, Hancock, J, Hough, R, Rowntree, C, Richards, S |
---|---|
বিন্যাস: | Journal article |
প্রকাশিত: |
2013
|
অনুরূপ উপাদানগুলি
অনুরূপ উপাদানগুলি
-
Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial.
অনুযায়ী: Vora, A, অন্যান্য
প্রকাশিত: (2013) -
UKALL 2003, A Randomised Trial Investigating Treatment Intensification for Children and Young Adults with Minimal Residual Disease Defined High Risk Acute Lymphoblastic Leukaema
অনুযায়ী: Vora, A, অন্যান্য
প্রকাশিত: (2012) -
Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial.
অনুযায়ী: Vora, A, অন্যান্য
প্রকাশিত: (2014) -
Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): A randomised controlled trial
অনুযায়ী: Vora, A, অন্যান্য
প্রকাশিত: (2014) -
UKALL 2003, A Randomised Trial Investigating Treatment Reduction for Children and Young Adults with Minimal Residual Disease Defined Low Risk Acute Lymphoblastic Leukaemia
অনুযায়ী: Vora, A, অন্যান্য
প্রকাশিত: (2010)